Prevention of vascular events in diabetes mellitus: which "antithrombotic" therapy?
Ceriello
A
A
Department of Pathology and Medicine, Clinical and Experimental, University of Udine, Italy.
Motz
E
E
D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D048909:Diabetes Complications; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D016491:Peripheral Vascular Diseases / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin